Mechanism of Action:
It selectively inhibits Monoamine Oxidase-B which causes the metabolism of dopamine and phenylethylamine.
It enhances and prolongs the Anti-Parkinsonian effects of levodopa but alone it is not of much benefit.
It is used in the early stages of Parkinson's disease. It can also be used in Senile Dementia and depression.